• Significant Deleveraging: Total liabilities decreased by $4.5 million, or 9.6%, quarter-over-quarter, while stockholders' equity increased 7.6%
  • Landmark Financing: R&D division in discussions with the European Investment Bank for financing of up to €25 million
  • Capital Structure Simplification: 4,874,126 Series B Warrants expired unexercised, eliminating ~38% of total warrant overhang with zero shareholder dilution
  • Real Estate Value: Wholly-owned facilities independently valued at approximately $15 million — exceeding current market capitalization  
  • Balance Sheet Transformation: Guidance projects stockholders' equity of $92.3 million by 2029, driven by a growing cash position of $62.9 million from internally generated cash flow